These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16961531)

  • 21. Treatment of toxic epidermal necrolysis with the combination of infliximab and high-dose intravenous immunoglobulin.
    Gaitanis G; Spyridonos P; Patmanidis K; Koulouras V; Nakos G; Tzaphlidou M; Bassukas ID
    Dermatology; 2012; 224(2):134-9. PubMed ID: 22572593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.
    Schneck J; Fagot JP; Sekula P; Sassolas B; Roujeau JC; Mockenhaupt M
    J Am Acad Dermatol; 2008 Jan; 58(1):33-40. PubMed ID: 17919775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic epidermal necrolysis in systemic lupus erythematosus.
    Horne NS; Narayan AR; Young RM; Frieri M
    Autoimmun Rev; 2006 Feb; 5(2):160-4. PubMed ID: 16431352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
    Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
    Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In a patient with toxic epidermal necrolysis, does intravenous immunoglobulin improve survival compared with supportive care?
    Wootton CI; Patel AN; Williams HC
    Arch Dermatol; 2011 Dec; 147(12):1437-40. PubMed ID: 22184767
    [No Abstract]   [Full Text] [Related]  

  • 27. The EuroSCAR study: cannot agree with the conclusions.
    Pehr K
    J Am Acad Dermatol; 2008 Nov; 59(5):898-9; author reply 899-900. PubMed ID: 19119105
    [No Abstract]   [Full Text] [Related]  

  • 28. Toxic epidermal necrolysis in the setting of systemic lupus erythematosus.
    Konda S; Fernandez AP; Berman B; Elgart G; Milikowski C; Alonso-Llamazares J
    Int J Dermatol; 2011 Oct; 50(10):1270-5. PubMed ID: 21950295
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pathogenesis research with clinical application. Successful treatment of Lyell's syndrome with intravenous immunoglobulin].
    Petzoldt D; Krutmann J
    Hautarzt; 1998 Dec; 49(12):950. PubMed ID: 9914897
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of staphylococcal toxic epidermal necrolysis.
    Rudolph RI; Schwartz W; Leyden JJ
    Arch Dermatol; 1974 Oct; 110(4):559-62. PubMed ID: 4416730
    [No Abstract]   [Full Text] [Related]  

  • 31. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fromowitz JS; Ramos-Caro FA; Flowers FP;
    Int J Dermatol; 2007 Oct; 46(10):1092-4. PubMed ID: 17910723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical uses of intravenous immunoglobulin.
    Jolles S; Sewell WA; Misbah SA
    Clin Exp Immunol; 2005 Oct; 142(1):1-11. PubMed ID: 16178850
    [No Abstract]   [Full Text] [Related]  

  • 33. Toxic epidermal necrolysis treated with low-dose intravenous immunoglobulin: immunohistochemical study of Fas and Fas-ligand expression.
    Ito K; Hara H; Okada T; Shimojima H; Suzuki H
    Clin Exp Dermatol; 2004 Nov; 29(6):679-80. PubMed ID: 15550154
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of i.v. IG therapy in dermatology.
    Fernandez AP; Kerdel FA
    Dermatol Ther; 2007; 20(4):288-305. PubMed ID: 17970894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Toxic epidermal necrolysis in children].
    Herrmann WA
    Ned Tijdschr Geneeskd; 1970 Oct; 114(43):1793-6. PubMed ID: 5528544
    [No Abstract]   [Full Text] [Related]  

  • 36. Toxic epidermal necrolysis successfully treated with etanercept.
    Gubinelli E; Canzona F; Tonanzi T; Raskovic D; Didona B
    J Dermatol; 2009 Mar; 36(3):150-3. PubMed ID: 19335689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic epidermal necrolysis in a child after carbamazepine dosage increment.
    Sevketoglu E; Hatipoglu S; Akman M; Bicer S
    Pediatr Emerg Care; 2009 Feb; 25(2):93-5. PubMed ID: 19225374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methimazole-induced toxic epidermal necrolysis in a 12-year-old girl.
    Ziora K; Oswiecimska J; Broll-Waska K; Szczepanska M; Szprynger K; Pieniazek W; Pindycka-Piaszczynska M; Sakiel S; Kawecki M
    J Paediatr Child Health; 2006; 42(7-8):472-3. PubMed ID: 16898888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest.
    Valiquette L; Low DE; McGeer AJ
    Clin Infect Dis; 2009 Nov; 49(9):1377-9. PubMed ID: 19788361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.